# RSV-F Vaccine Dose Ranging Study in Young Women

> **NCT01704365** · PHASE2 · COMPLETED · sponsor: **Novavax** · enrollment: 330 (actual)

## Conditions studied

- Respiratory Syncytial Virus (RSV)

## Interventions

- **BIOLOGICAL:** Low dose RSV-F Vaccine with Adjuvant
- **BIOLOGICAL:** Low dose RSV-F Vaccine without Adjuvant
- **BIOLOGICAL:** High dose RSV-F Vaccine with Adjuvant
- **BIOLOGICAL:** High dose RSV-F Vaccine without Adjuvant
- **BIOLOGICAL:** Low dose RSV-F Vaccine with Adjuvant [Bedside Mixing]
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01704365
- **Lead sponsor:** Novavax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-04
- **Final completion:** 2013-05
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2014-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01704365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01704365, "RSV-F Vaccine Dose Ranging Study in Young Women". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01704365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*